Skip to content
OpenCapital
Get started

Celcuity CELC Increase (Decrease) in Other Current Assets

Increase (Decrease) in Other Current Assets at other companies

TG Therapeutics logo
TG TherapeuticsTGTX
——

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentAssets.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's increase (decrease) in other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's increase (decrease) in other current assets?
Celcuity (CELC) reported increase (decrease) in other current assets of $976K in Q1 2026.
How has Celcuity's increase (decrease) in other current assets changed year-over-year?
Celcuity's increase (decrease) in other current assets increased by 206.9% year-over-year, from $318K to $976K.
What is the long-term trend for Celcuity's increase (decrease) in other current assets?
Over 2 years (2022 to 2024), Celcuity's increase (decrease) in other current assets has grown at a -29.2% compound annual growth rate (CAGR), from $5.53M to -$2.77M.